10 Stocks with Potential to Rise 1000 Percent

5. IonQ, Inc. (NYSE:IONQ)

Number of Hedge Fund Holders: 28

IonQ, Inc. (NYSE:IONQ) is a quantum computing company that develops and operates quantum systems based on trapped ion technology. Its core offering includes cloud-accessible quantum computers that are integrated with major platforms such as Amazon Braket, Microsoft Azure, and Google Cloud. IONQ also develops custom quantum solutions for commercial and government clients across sectors like finance, logistics, and defense. The company focuses on advancing both quantum hardware and software, with a roadmap to increase the number of algorithmic qubits and improve error correction. IONQ ranked 10^th on our recent list of 15 Best Small Cap AI Stocks to Buy Right Now.

IonQ, Inc. (NYSE:IONQ) achieved its best year ever in 2024, with full-year bookings growing 47% to $95.6 million and revenue nearly doubling to $43.1 million, exceeding guidance ranges. The company has made significant strategic moves in quantum networking by acquiring Qubitekk and announcing a controlling stake in ID Quantique, which will give IonQ control of nearly 900 patents across quantum key distribution, quantum sensing, quantum networking, and quantum computing. On the technology front, the company delivered its first Forte enterprise system to Quantum Basel and the Air Force Research Lab while making progress on the next-generation varium-based system called Tempo. IONQ is one of the stocks that will go up 1000 percent.

IonQ, Inc. (NYSE:IONQ) is reconfirming its confidence in achieving #AQ 64 by the end of 2025, which will be demonstrated on their next-generation Varium-based system capable of circa 3,000 high-quality gate operations. Looking ahead to 2025, management projects revenue between $75 million to $95 million for the full year, with Q1 guidance of $7 million to $8 million. The company has also launched a $500 million at-the-market facility to accelerate its networking business and create new lines of growth in promising application areas. Notable partnerships and collaborations include work with AstraZeneca on drug discovery, ANSYS in computer-aided engineering, and General Dynamics Information Technology for fraud and anomaly detection solutions.